It is demonstrated that CAR-T cells secreting IL-15/IL-15Ra complex display comparable efficacy as secreting IL-15 alone with reduced adverse effects in hematological cancer [32]. Here, IL15 is linked to hematopoietic and lymphoid cell neoplasm.